5,6-Dibromo-N-methyltryptamine

From WikiMD's Medical Encyclopedia

Revision as of 05:29, 16 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


5,6-Dibromo-N-methyltryptamine[edit]

Chemical structure of 5,6-Dibromo-N-methyltryptamine

5,6-Dibromo-N-methyltryptamine (5,6-diBr-NMT) is a synthetic compound belonging to the class of tryptamines, which are structurally related to the naturally occurring neurotransmitter serotonin. This compound is characterized by the presence of two bromine atoms at the 5 and 6 positions of the indole ring, as well as a methyl group attached to the nitrogen atom of the ethylamine side chain.

Chemical Properties[edit]

5,6-Dibromo-N-methyltryptamine is a derivative of N-methyltryptamine (NMT), with the addition of bromine atoms. The presence of these halogen atoms can significantly alter the compound's lipophilicity, binding affinity, and pharmacokinetics. The molecular formula of 5,6-diBr-NMT is C11H12Br2N2, and it has a molecular weight of 332.04 g/mol.

Synthesis[edit]

The synthesis of 5,6-Dibromo-N-methyltryptamine typically involves the bromination of N-methyltryptamine. This process requires careful control of reaction conditions to ensure selective bromination at the 5 and 6 positions. The synthesis may involve the use of brominating agents such as N-bromosuccinimide (NBS) in the presence of a suitable solvent and catalyst.

Pharmacology[edit]

As a tryptamine derivative, 5,6-diBr-NMT is of interest in the study of psychoactive compounds. Tryptamines are known to interact with serotonin receptors, particularly the 5-HT2A receptor, which is implicated in the effects of many psychedelic substances. However, the specific pharmacological profile of 5,6-diBr-NMT, including its receptor binding affinities and psychoactive effects, has not been extensively studied.

Potential Applications[edit]

Research into halogenated tryptamines like 5,6-diBr-NMT may provide insights into the structure-activity relationships of these compounds. Understanding how halogenation affects receptor binding and activity could lead to the development of new therapeutic agents targeting the central nervous system.

Safety and Legal Status[edit]

The safety profile of 5,6-Dibromo-N-methyltryptamine is not well-documented, and it is not approved for medical use. As with many synthetic tryptamines, it may be subject to legal restrictions in various jurisdictions due to its potential psychoactive properties.

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Get started with evidence based, physician-supervised

affordable GLP-1 weight loss injections

Now available in New York City and Philadelphia:

✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=5,6-Dibromo-N-methyltryptamine&oldid=6298584"